Company Overview of ETEX Corporation
ETEX Corporation develops, manufactures, and commercializes nanocrystalline calcium phosphate-based biomaterials for the repair and regeneration of bone damaged by trauma or disease. It offers porous, injectable, and moldable bone substitute materials; and osteoinductive bone graft substitutes. ETEX Corporation has a strategic partnership with Pfizer. The company was founded in 1989 and is headquartered in Cambridge, Massachusetts.
675 Massachusetts Avenue
Cambridge, MA 02139
Founded in 1989
Key Executives for ETEX Corporation
Similar Private Companies By Industry
|Sierra Diagnostics Inc||United States|
|Genteric, Inc.||United States|
|Online Disruptive Technologies, Inc.||United States|
|Sentigen BioSciences, Inc.||United States|
|ViaCyte, Inc.||United States|
Recent Private Companies Transactions
October 1, 2014
To contact ETEX Corporation, please visit www.etexcorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.